v1
Phase 1 Study Of The Novel Kinesin Spindle Protein Inhibitor ARRY-520 + Carfilzomib (Car) In Patients With Relapsed and/Or Refractory Multiple Myeloma (RRMM)
Identifier:nobleid.org/w1/20260515/FD21339B
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/FD21339B)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims